Literature DB >> 14580763

Activation of G-protein-coupled receptors: a common molecular mechanism.

Sadashiva S Karnik1, Camelia Gogonea, Supriya Patil, Yasser Saad, Takanobu Takezako.   

Abstract

G-protein-coupled receptors (GPCRs) are a large family of proteins that contain a seven transmembrane helical structural motif. They mediate responses to several ligands by binding and activating intracellular heterotrimeric G proteins. Since the cloning of the first GPCR, insights gained from structure-function studies, genetics and drug development have contributed to uncovering a common mechanism that explains the activation of diverse GPCRs by their cognate agonists. This mechanism takes into consideration the conservation of the structure-function relationship in the basic seven transmembrane structural motif, and the dynamic changes in receptor conformation that are associated with activation. Combining models derived from the X-ray structure of rhodopsin with structure-function data allows a deeper understanding of the activation mechanism of GPCRs.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14580763     DOI: 10.1016/j.tem.2003.09.007

Source DB:  PubMed          Journal:  Trends Endocrinol Metab        ISSN: 1043-2760            Impact factor:   12.015


  39 in total

Review 1.  Pharmacoperones: a new therapeutic approach for diseases caused by misfolded G protein-coupled receptors.

Authors:  Alfredo Ulloa-Aguirre; P Michael Conn
Journal:  Recent Pat Endocr Metab Immune Drug Discov       Date:  2011-01

2.  Interactions of human melanocortin 4 receptor with nonpeptide and peptide agonists.

Authors:  Irina D Pogozheva; Biao-Xin Chai; Andrei L Lomize; Tung M Fong; David H Weinberg; Ravi P Nargund; Michael W Mulholland; Ira Gantz; Henry I Mosberg
Journal:  Biochemistry       Date:  2005-08-30       Impact factor: 3.162

Review 3.  International Union of Basic and Clinical Pharmacology. XCIX. Angiotensin Receptors: Interpreters of Pathophysiological Angiotensinergic Stimuli [corrected].

Authors:  Sadashiva S Karnik; Hamiyet Unal; Jacqueline R Kemp; Kalyan C Tirupula; Satoru Eguchi; Patrick M L Vanderheyden; Walter G Thomas
Journal:  Pharmacol Rev       Date:  2015-10       Impact factor: 25.468

Review 4.  Oligomerization of G protein-coupled receptors: past, present, and future.

Authors:  Paul S-H Park; Slawomir Filipek; James W Wells; Krzysztof Palczewski
Journal:  Biochemistry       Date:  2004-12-21       Impact factor: 3.162

Review 5.  The serotonin1A receptor: a representative member of the serotonin receptor family.

Authors:  Thomas J Pucadyil; Shanti Kalipatnapu; Amitabha Chattopadhyay
Journal:  Cell Mol Neurobiol       Date:  2005-06       Impact factor: 5.046

Review 6.  Homology modeling of opioid receptor-ligand complexes using experimental constraints.

Authors:  Irina D Pogozheva; Magdalena J Przydzial; Henry I Mosberg
Journal:  AAPS J       Date:  2005-10-05       Impact factor: 4.009

7.  Ligand-induced partitioning of human CXCR1 chemokine receptors with lipid raft microenvironments facilitates G-protein-dependent signaling.

Authors:  Xuanmao Jiao; Ning Zhang; Xuehua Xu; Joost J Oppenheim; Tian Jin
Journal:  Mol Cell Biol       Date:  2005-07       Impact factor: 4.272

8.  Oligomerization of the fifth transmembrane domain from the adenosine A2A receptor.

Authors:  Damien Thévenin; Tzvetana Lazarova; Matthew F Roberts; Clifford R Robinson
Journal:  Protein Sci       Date:  2005-06-29       Impact factor: 6.725

9.  In vitro pharmacological characterization of AM1241: a protean agonist at the cannabinoid CB2 receptor?

Authors:  B B Yao; S Mukherjee; Y Fan; T R Garrison; A V Daza; G K Grayson; B A Hooker; M J Dart; J P Sullivan; M D Meyer
Journal:  Br J Pharmacol       Date:  2006-08-07       Impact factor: 8.739

10.  Structure of the human angiotensin II type 1 (AT1) receptor bound to angiotensin II from multiple chemoselective photoprobe contacts reveals a unique peptide binding mode.

Authors:  Dany Fillion; Jérôme Cabana; Gaétan Guillemette; Richard Leduc; Pierre Lavigne; Emanuel Escher
Journal:  J Biol Chem       Date:  2013-02-05       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.